Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/23/1997 | WO1997002348A1 Immunogenic detoxified mutant of cholera toxins |
01/23/1997 | WO1997002347A1 A human map kinase homolog |
01/23/1997 | WO1997002346A2 Novel human chromosome 16 genes, compositions, methods of making and using same |
01/23/1997 | WO1997002345A1 Tnf modulation |
01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
01/23/1997 | WO1997002343A1 Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products |
01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
01/23/1997 | WO1997002291A1 Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen |
01/23/1997 | WO1997002287A1 Parevins and tachytegrins |
01/23/1997 | WO1997002281A1 Novel detection methods for cryptosporidium |
01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
01/23/1997 | WO1997002049A1 Neuronal progenitor cells and uses thereof |
01/23/1997 | WO1997002048A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
01/23/1997 | WO1997001952A1 Delayed ripening tomato plants |
01/23/1997 | WO1997000063A3 Urocortin peptides |
01/23/1997 | WO1996041877A3 Malarial pre-erythrocytic stage polypeptide molecules |
01/23/1997 | WO1996040992A3 Probe masking method of reducing background in an amplification reaction |
01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
01/23/1997 | WO1996040939A3 Expression of functional vertebrate phospholipases in yeast |
01/23/1997 | WO1996040918A3 Novel cd40l mutein |
01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
01/23/1997 | WO1996040253A3 Rna photocleavage using texaphyrins |
01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
01/23/1997 | WO1996025947A3 Induction of e-selectin for targetting therapeutic agents |
01/23/1997 | DE19628873A1 Cyclitol-ubiquinone oxido:reductase enzyme |
01/23/1997 | DE19526485A1 Rekombinant hergestellte Leucinaminopeptidase aus Aspergillus sojae Recombinantly produced leucine aminopeptidase from Aspergillus sojae |
01/23/1997 | CA2226417A1 Neuronal progenitor cells and uses thereof |
01/23/1997 | CA2226258A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
01/23/1997 | CA2226121A1 Parevins and tachytegrins |
01/23/1997 | CA2226088A1 Delayed ripening tomato plants |
01/23/1997 | CA2226011A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
01/23/1997 | CA2225824A1 Breast specific genes and proteins |
01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
01/23/1997 | CA2222722A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
01/23/1997 | CA2198896A1 A method for determining the integrity of nucleic acid |
01/23/1997 | CA2198729A1 A novel human map kinase homolog |
01/22/1997 | EP0754765A2 DNA sequencing and DNA terminators |
01/22/1997 | EP0754764A2 Method and reagent for the specific determination of mRNA |
01/22/1997 | EP0754757A2 A plant promoter and an application thereof |
01/22/1997 | EP0754756A1 Process for producing l-lysine |
01/22/1997 | EP0754755A2 Recombinant autologous Epstein-Barr viral fusion proteins, test kits containing them and methods for the detection of Epstein-Barr virus specific antibodies |
01/22/1997 | EP0754754A1 Fk506-binding protein gene |
01/22/1997 | EP0754753A1 Novel human tissue-type plasminogen activator variant |
01/22/1997 | EP0754751A1 Novel deoxyribonuclease |
01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
01/22/1997 | EP0754240A1 Ligase/polymerase-mediated genetic bit analysis?tm of single nucleotide polymorphisms and its use in genetic analysis |
01/22/1997 | EP0754237A1 An adenovirus supervector system |
01/22/1997 | EP0754236A1 Reduction of endogenous seed protein levels in plants |
01/22/1997 | EP0754235A1 Method for producing altered starch from potato plants |
01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
01/22/1997 | EP0754232A1 Plant lysophosphatidic acid acyltransferases |
01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
01/22/1997 | EP0754226A1 Recombinant equine herpesviruses |
01/22/1997 | EP0754225A1 Transgenic non-human animals capable of producing heterologous antibodies |
01/22/1997 | EP0754224A1 Ice and ice-like compositions and methods of making same |
01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
01/22/1997 | EP0754192A1 Circularly permuted ligands and circularly permuted chimeric molecules |
01/22/1997 | EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
01/22/1997 | EP0754188A1 Oligonucleotides with anti-cytomegalovirus activity |
01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
01/22/1997 | EP0754056A1 Soft agar penetration-defective mutants |
01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
01/22/1997 | EP0753992A1 Antiviral transgenic plants, vectors, cells and methods |
01/22/1997 | EP0633891B1 Synthesis of oligonucleotides |
01/22/1997 | EP0555438B1 Streptolysin o variants |
01/22/1997 | EP0549581B1 Framework mutated antibodies and their preparation |
01/22/1997 | EP0502979B1 Beta retinoic acid response elements compositions and assays |
01/22/1997 | EP0500659B1 Monoclonal antibodies |
01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
01/22/1997 | CN1141078A Self-addressable self-assembling microelectronic system and devices for molecular biological analysis and diagnostics |
01/22/1997 | CN1141062A Use of alpha'-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose |
01/22/1997 | CN1141061A Thrombopoietin |
01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
01/22/1997 | CN1141057A Recombinant yeasts for effective fermentation of glucose and xylose |
01/22/1997 | CN1140999A Anti-fungal methods and materials |
01/22/1997 | CN1140762A Methods for polymerase chain reaction premplification sterilization by exonucleases in presence of phosphorothioated primers |
01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
01/22/1997 | CN1033839C Processing method for binding-inducing composition |
01/22/1997 | CA2181219A1 Dna sequencing and dna terminators |
01/21/1997 | US5596132 Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene |
01/21/1997 | US5596131 Regeneration of graminaceous plants of the subfamily pooideae from protoplasts |
01/21/1997 | US5596092 Extraction of genomic DNA from blood using cationic detergents |
01/21/1997 | US5596091 Dna and rna for gene expression for diagnosis |
01/21/1997 | US5596090 Treatment of septic shock, adult respiratory distress syndrome |
01/21/1997 | US5596086 Dimers with phosphodiester linkages for hybridization to target rna or dna sequences |
01/21/1997 | US5596079 Mimetics of senescent cell derived inhibitors of DNA synthesis |
01/21/1997 | US5596071 Bacillus thuringiensis toxins active against hymenopteran pests |
01/21/1997 | US5595978 Composition and method for treatment of CMV retinites |
01/21/1997 | US5595904 Family of map2 protein kinases |
01/21/1997 | US5595903 Expression vectors, host cells |